Glaukos Corp
Change company Symbol lookup
Select an option...
GKOS Glaukos Corp
FICO Fair Isaac Corp
CBDL Cbd Life Sciences Inc
HKXCY Hong Kong Exchanges and Clearing Ltd
TOMZ TOMI Environmental Solutions Inc
GDXD MicroSectors? Gold Miners -3X Inverse Leveraged ETNs
CWK Cushman & Wakefield PLC
NAUT Nautilus Biotechnology Inc
ZSANQ Zosano Pharma Corp
CHX ChampionX Corp
Go

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. It is focused on developing novel therapies for the treatment of glaucoma, corneal disorders, and retinal disease. Its product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products, which includes insertion of a micro-scale device or drug delivery system designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma and MIGS biosensors to measure pressure within the eye; bio-activated pharmaceuticals to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders, such as keratoconus or refractive disorders; transdermal pharmaceuticals that are applied to the eyelid and designed to treat dry eye, presbyopia, glaucoma and other ocular surface diseases and disorders; and micro-invasive, bio-erodible sustained release drug delivery implants that are designed to elute pharmaceuticals.

Closing Price
$50.00
Day's Change
-0.37 (-0.73%)
Bid
--
Ask
--
B/A Size
--
Day's High
51.43
Day's Low
49.89
Volume
(Average)
Volume:
637,389

10-day average volume:
622,713
637,389
  • Prev Close
    50.37
  • Today's Open
    50.40
  • Day's Range
    49.89-51.43
  • Avg Vol (10-day)
    622.7K
  • Last (time)
    7:00p ET 08/11/22
  • Last (size)
    3.2K
  • 52-Wk Range
    33.33 - 64.49
    LowHigh
  • (04/08/22 - 05/10/22)
    22.47%
  • 54.5%
  • Market Cap
    2.4B
  • Shares Outstanding
    47.6M
  • -1.19
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.4
  • 90.43
  • (% of float 07/29/22)
    3.52

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.